Company Information


Brussels, Belgium


Jean-Christophe Tellier


UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. Arix has a strategic agreement to provide to UCB reasonable access to its process of investing in its portfolio companies, including participation in sourcing, screening, due diligence and joint business building with a view to facilitating UCB’s participation in such Group Businesses. The focus of the strategic partnership is in immunology, neurology and bone and managed through a joint advisory committee.

Our Partners

Learn more about our other partners.